Outcomes of Total Hip Arthroplasty Performed for HIV-Associated Osteonecrosis in China: A Retrospective Cohort Study

Author:

Li Kangpeng1,Ma Rui1,Zhao Rugang1,Zhang Qiang1

Affiliation:

1. Department of Orthopaedics, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China

Abstract

Background: In the post-epidemic era, Acquired Immune Deficiency Syndrome (AIDS) remains one of the most prevalent and detrimental infectious diseases worldwide. The incidence of osteonecrosis of the femoral head (ONFH) in AIDS patients is 100 times higher than that in healthy individuals. Although Total Hip Arthroplasty (THA) is ultimately necessary for most patients, there is still a dearth of evidence regarding its safety and efficacy in Chinese AIDS patients. Methods: The clinical data of 49 patients who met the inclusion and exclusion criteria were retrospectively analyzed. Simultaneously, we categorized patients whose hemoglobin and albumin met a specific threshold as the optimized group and performed group comparisons. Results: There are statistical differences in Harris score and VAS score pre- and post-operation, with a low overall complication rate. Notably, no disparities were observed between the optimized group and the partial optimized group in terms of overall conditions, laboratory examination indicators, severity of ONFH, surgical outcomes, surgical complications, pain perception or functional limitations. Furthermore, no correlation was found between CD4+ T lymphocytes and hemoglobin levels, albumin levels, white blood cell count, or platelet count. Conclusion: THA is safe and effective in Chinese AIDS patients with ONFH. However, optimal treatment has limited efficacy in AIDS patients undergoing THA for ONFH. The reconsideration and evaluation of the predictive value of CD4+ T lymphocytes for postoperative complications in joint replacement procedures is warranted.

Publisher

Bentham Science Publishers Ltd.

Reference20 articles.

1. Li K.; Liu B.; Ma R.; Zhang Q.; HIV tissue reservoirs: Current advances in research. AIDS Patient Care STDS 2023,37(6),284-296

2. Cribbs S.K.; Crothers K.; Morris A.; Pathogenesis of HIV-related lung disease: Immunity, infection, and inflammation. Physiol Rev 2020,100(2),603-632

3. Lucas S.; Nelson A.M.; HIV and the spectrum of human disease. J Pathol 2015,235(2),229-241

4. Schouten J.; Wit F.W.; Stolte I.G.; Kootstra N.A.; van der Valk M.; Geerlings S.E.; Prins M.; Reiss P.; Reiss P.; Wit F.W.N.M.; van der Valk M.; Schouten J.; Kooij K.W.; van Zoest R.A.; Elsenga B.C.; Prins M.; Stolte I.G.; Martens M.; Moll S.; Berkel J.; Moller L.; Visser G.R.; Welling C.; Zaheri S.; Hillebregt M.M.J.; Gras L.A.J.; Ruijs Y.M.C.; Benschop D.P.; Reiss P.; Kootstra N.A.; Harskamp-Holwerda A.M.; Maurer I.; Mangas Ruiz M.M.; Girigorie A.F.; van Leeuwen E.; Janssen F.R.; Heidenrijk M.; Schrijver J.H.N.; Zikkenheiner W.; Wezel M.; Jansen-Kok C.S.M.; Geerlings S.E.; Godfried M.H.; Goorhuis A.; van der Meer J.T.M.; Nellen F.J.B.; van der Poll T.; Prins J.M.; Reiss P.; van der Valk M.; Wiersinga W.J.; Wit F.W.N.M.; van Eden J.; Henderiks A.; van Hes A.M.H.; Mutschelknauss M.; Nobel H.E.; Pijnappel F.J.J.; Westerman A.M.; de Jong J.; Postema P.G.; Bisschop P.H.L.T.; Serlie M.J.M.; Lips P.; Dekker E.; de Rooij S.E.J.A.; Willemsen J.M.R.; Vogt L.; Schouten J.; Portegies P.; Schmand B.A.; Geurtsen G.J.; ter Stege J.A.; Klein Twennaar M.; van Eck-Smit B.L.F.; de Jong M.; Richel D.J.; Verbraak F.D.; Demirkaya N.; Visser I.; Ruhe H.G.; Nieuwkerk P.T.; van Steenwijk R.P.; Dijkers E.; Majoie C.B.L.M.; Caan M.W.A.; Su T.; van Lunsen H.W.; Nievaard M.A.F.; van den Born B.J.H.; Stroes E.S.G.; Mulder W.M.C.; Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: The AGEhIV cohort study. Clin Infect Dis 2014,59(12),1787-1797

5. Bayard C.; Ledergerber B.; Flepp M.; Lecompte T.; Moulin E.; Hoffmann M.; Weber R.; Staehelin C.; Di Benedetto C.; Fux C.A.; Tarr P.E.; Hasse B.; Aubert V.; Battegay M.; Bernasconi E.; Böni J.; Braun D.L.; Bucher H.C.; Calmy A.; Cavassini M.; Ciuffi A.; Dollenmaier G.; Egger M.; Elzi L.; Fehr J.; Fellay J.; Furrer H.; Fux C.A.; Günthard H.F.; Haerry D.; Hasse B.; Hirsch H.H.; Hoffmann M.; Hösli I.; Kahlert C.; Kaiser L.; Keiser O.; Klimkait T.; Kouyos R.D.; Kovari H.; Ledergerber B.; Martinetti G.; Martinez de Tejada B.; Marzolini C.; Metzner K.J.; Müller N.; Nicca D.; Pantaleo G.; Paioni P.; Rauch A.; Rudin C.; Scherrer A.U.; Schmid P.; Speck R.; Stöckle M.; Tarr P.; Trkola A.; Vernazza P.; Wandeler G.; Weber R.; Yerly S.; Associations between antiretroviral treatment and avascular bone necrosis: The swiss HIV cohort study. Open Forum Infect Dis 2017,4(4),ofx177

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3